'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease

Nature Reviews Rheumatology

Volumn 11, Issue 12, 2015, Pages 731-740

  McGonagle, Dennis ^a   Aydin, Sibel Zehra ^b   Gül, Ahmet ^c   Mahr, Alfred ^d   Direskeneli, Haner ^e  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

^c ISTANBUL UNIVERSITY   (Turkey)

^d SAINT LOUIS HOSPITAL   (France)

^e MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GRANULOCYTE COLONY STIMULATING FACTOR; HLA B ANTIGEN; HLA B51 ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ALLELE; ANTIGEN BINDING; BEHCET DISEASE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOID CELL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PSORIATIC ARTHRITIS; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SPONDYLOARTHROPATHY; ANIMAL; GENE; GENETICS; IMMUNOLOGY; SPONDYLARTHRITIS;

ANIMALS; BEHCET SYNDROME; GENES, MHC CLASS I; HUMANS; SPONDYLARTHRITIS;

EID: 84948712615     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2015.147     Document Type: Review

References (110)

1. McGonagle, D.,&McDermott, M. F A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006
2. Direskeneli, H. Behçets disease: infectious aetiology, new autoantigens, and HLA B51. Ann. Rheum. Dis. 60, 996-1002 (2001
3. Gul, A. Behçets disease as an autoinflammatory disorder. Curr. Drug Targets Inflamm. Allergy 4, 81-83 (2005
4. No authors listed] Criteria for diagnosis of Behçets disease. International Study Group for Behçets Disease. Lancet 335, 1078-1080 (1990
5. Moll, J. M., Haslock, I., Macrae, I. F.,&Wright, V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiters disease, the intestinal arthropathies, and Behçets syndrome. Medicine (Baltimore) 53, 343-364 (1974
6. Goyette, P.,&Rioux, J. D. High-density mapping of the MHC identifies a shared role for HLA-DRB1 01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 47, 172-179 (2015
7. Saadoun, D., et al. Azathioprine in severe uveitis of Behçets disease. Arthritis Care Res. (Hoboken) 62, 1733-1738 (2010
8. McGonagle, D.,&Georgouli, T. The importance of Mechnikovs thorn for an improved understanding of 21st century medicine and immunology: a view from the eye. Scand. J. Immunol. 68, 129-139 (2008
9. Kastner, D. L., Aksentijevich, I.,&Goldbach-Mansky, R. Autoinflammatory disease reloaded: a clinical perspective. Cell 140, 784-790 (2010
10. Hayday, A. C. T cells and the lymphoid stress-surveillance response. Immunity 31, 184-196 (2009
11. Robinson, P. C.,&Brown, M. A. Genetics of ankylosing spondylitis. Mol. Immunol. 57, 2-11 (2014
12. Gordon, K. B., et al A phase 2 trial of guselkumab versus adalimumab for plaque psoriasis. N. Engl. J. Med. 373, 136-144 (2015
13. Khan, M. A., Mathieu, A., Sorrentino, R.,&Akkoc, N. The pathogenetic role of HLA B27 and its subtypes. Autoimmun. Rev. 6, 183-189 (2007
14. Gupta, R., Debbaneh, M. G.,&Liao, W. Genetic epidemiology of psoriasis. Curr. Dermatol. Rep. 3, 61-78 (2014
15. de Menthon, M., Lavalley, M. P., Maldini, C., Guillevin, L.,&Mahr, A. HLA B51/B5 and the risk of Behçets disease: a systematic review and meta-Analysis of case-control genetic association studies. Arthritis Rheum. 61, 1287-1296 (2009
16. Belizaire, R.,&Unanue, E. R. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc. Natl Acad. Sci. USA 106, 17463-17468 (2009
17. Anfossi, N., et al Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331-342 (2006
18. Ombrello, M. J., et al. Behçet disease-Associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc. Natl Acad. Sci. USA 111, 8867-8872 (2014
19. Wallace, G. R. HLA B 51 the primary risk in Behçet disease. Proc. Natl Acad. Sci. USA 111, 8706-8707 (2014
20. Gul, A.,&Ohno, S. HLA B 51 and Behçet disease. Ocul. Immunol. Inflamm. 20, 37-43 (2012
21. Ombrello, M. J., Kastner, D. L.,&Remmers, E. F. Endoplasmic reticulum-Associated amino-peptidase 1 and rheumatic disease: genetics. Curr. Opin. Rheumatol. 27, 349-356 (2015
22. Tran, T. M.,&Colbert, R. A. Endoplasmic reticulum aminopeptidase 1 and rheumatic disease: functional variation. Curr. Opin. Rheumatol. 27, 357-363 (2015
23. Robinson, P. C., et al. ERAP2 is associated with ankylosing spondylitis in HLA B27 positive and HLA B27 negative patients. Ann. Rheum. Dis. 74, 1627-1629 (2015
24. Kirino, Y., et al. Genome-wide association analysis identifies new susceptibility loci for Behçets disease and epistasis between HLA B 51 and ERAP1. Nat. Genet. 45, 202-207 (2013
25. Cortes, A., et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat. Commun. 6, 7146 (2015
26. Saric, T., et al. An IFN ? induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I presented peptides. Nat. Immunol. 3, 1169-1176 (2002
27. Reeves, E., Colebatch-Bourn, A., Elliott, T., Edwards, C. J.,&James, E. Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis. Proc. Natl Acad. Sci. USA 111, 17594-17599 (2014
28. Gul, A., et al. Immunohistology of skin pathergy reaction in Behçets disease. Br. J. Dermatol. 132, 901-907 (1995
29. Yan, J., et al. In vivo role of ER associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J. Exp. Med. 203, 647-659 (2006
30. Guasp, P., et al. The peptidome of the Behçets disease-Associated HLA B 51:01 includes two sub-peptidomes differentially shaped by ERAP1. Arthritis. Rheumatol. doi:10.1002/art.39430
31. Costantino, F., et al. ERAP1 gene expression is influenced by nonsynonymous polymorphisms associated with predisposition to spondyloarthritis. Arthritis Rheumatol. 67, 1525-1534 (2015
32. Saruhan-Direskeneli, G., et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am. J. Hum. Genet. 93, 298-305 (2013
33. Haliloglu, T., Gul, A.,&Erman, B. Predicting important residues and interaction pathways in proteins using Gaussian network model: binding and stability of HLA proteins. PLoS Comput. Biol. 6, e1000845 (2010
34. Reeves, E., Edwards, C. J., Elliott, T.,&James, E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J. Immunol. 191, 35-43 (2013
35. Chen, L., et al Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA B27. Arthritis Rheumatol. 66, 284-294 (2014
36. Seregin, S. S., et al. Endoplasmic reticulum aminopeptidase 1 alleles associated with increased risk of ankylosing spondylitis reduce HLA B27 mediated presentation of multiple antigens. Autoimmunity 46, 497-508 (2013
37. Glocker, E. O., et al. Inflammatory bowel disease and mutations affecting the interleukin 10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009
38. Fan, X., et al. Comparison of clinical features of HLA-Cw 0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm. Venereol. 87, 335-340 (2007
39. Gudjonsson, J. E., et al. Distinct clinical differences between HLA-Cw0602 positive and negative psoriasis patients-An analysis of 1019 HLA C and HLA B typed patients. J. Invest. Dermatol. 126, 740-745 (2006
40. Wilson, F. C., et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 61, 233-239 (2009
41. Winchester, R., et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 64, 1134-1144 (2012
42. Okada, Y., et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. Am. J. Hum. Genet. 95, 162-172 (2014
43. McGonagle, D., Benjamin, M.,&Tan, A. L. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?. Curr. Opin. Rheumatol. 21, 340-347 (2009
44. Ash, Z. R., et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann. Rheum. Dis. 71, 553-556 (2012
45. Aydin, S. Z., et al. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology 225, 231-235 (2012
46. Maldini, C., Lavalley, M. P., Cheminant, M., de Menthon, M.,&Mahr, A. Relationships of HLA B51 or B5 genotype with Behçets disease clinical characteristics: systematic review and meta-Analyses of observational studies. Rheumatology (Oxford) 51, 887-900 (2012
47. Gul, A., et al. Lack of association of HLA B 51 with a severe disease course in Behçets disease. Rheumatology (Oxford) 40, 668-672 (2001
48. McGonagle, D., Stockwin, L., Isaacs, J.,&Emery, P. An enthesitis based model for the pathogenesis of spondyloarthropathy. Additive effects of microbial adjuvant and biomechanical factors at disease sites. J. Rheumatol. 28, 2155-2159 (2001
49. McGonagle, D., Thomas, R. C.,&Schett, G. Spondyloarthritis: may the force be with you?. Ann. Rheum. Dis. 73, 321-323 (2014
50. Jacques, P., et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann. Rheum. Dis. 73, 437-445 (2014
51. Aydin, S. Z., et al. Validation of ultrasound imaging for Achilles entheseal fibrocartilage in bovines and description of changes in humans with spondyloarthritis. Ann. Rheum. Dis. 69, 2165-2168 (2010
52. Chan, C. C. Relationship between sympathetic ophthalmia, phacoanaphylatic endophthalmitis, and Vogt-Koyanagi-Harada disease. Ophthalmology 95, 619-624 (1988
53. Marak, G. E. Jr. Phacoanaphylactic endophthalmitis. Surv. Ophthalmol. 36, 325-339 (1992
54. Martin, T. M., Smith, J. R.,&Rosenbaum, J. T. Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies. Curr. Opin. Rheumatol. 14, 337-341 (2002
55. Savill, J., Dransfield, I., Gregory, C.,&Haslett, C A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975 (2002
56. Munoz-Fernandez, S., et al. Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis. Arthritis Rheum. 60, 1985-1990 (2009
57. Bandinelli, F., et al. Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropathy. Rheumatology (Oxford) 50, 1275-1279 (2011
58. Ergun, T., Gurbuz, O., Harvell, J., Jorizzo, J.,&White, W. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçets disease. Int. J. Dermatol. 37, 929-933 (1998
59. Melikoglu, M., et al. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. J. Immunol. 177, 6415-6421 (2006
60. Dilsen, N., et al. Comparative study of the skin pathergy test with blunt and sharp needles in Behçets disease: confirmed specificity but decreased sensitivity with sharp needles. Ann. Rheum. Dis. 52, 823-825 (1993
61. Heilborn, J. D., et al. The cathelicidin anti-microbial peptide LL 37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389 (2003
62. Mumcu, G., et al. Salivary levels of antimicrobial peptides Hnp 1-3, Ll 37 and S100 in Behçets disease. Arch. Oral Biol. 57, 642-646 (2012
63. Hatemi, G., et al. The pustular skin lesions in Behçets syndrome are not sterile. Ann. Rheum. Dis. 63, 1450-1452 (2004
64. Mumcu, G., Inanc, N., Yavuz, S.,&Direskeneli, H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçets disease. Clin. Exp. Rheumatol. 25, S27-S33 (2007
65. Verity, D. H., Wallace, G. R., Vaughan, R. W.,&Stanford, M. R. Behçets disease: from Hippocrates to the third millennium. Br. J. Ophthalmol. 87, 1175-1183 (2003
66. Mumcu, G., et al. Oral health is impaired in Behçets disease and is associated with disease severity. Rheumatology (Oxford) 43, 1028-1033 (2004
67. Fresko, I., Yazici, H., Bayramicli, M., Yurdakul, S.,&Mat, C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçets syndrome. Ann. Rheum. Dis. 52, 619-620 (1993
68. Bergfeldt, L., Insulander, P., Lindblom, D., Moller, E.,&Edhag, O. HLA B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am. J. Med. 85, 12-18 (1988
69. Tascilar, K., et al. Vascular involvement in Behçets syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53, 2018-2022 (2014
70. McGonagle, D., et al. The role of biomechanical factors and HLA B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum. 46, 489-493 (2002
71. Puhakka, K. B., et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol. 44, 218-229 (2003
72. Marzo-Ortega, H., et al. Baseline and 1 year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA B27 and disease extent and persistence. Ann. Rheum. Dis. 68, 1721-1727 (2009
73. Rudwaleit, M., et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 60, 717-727 (2009
74. Castillo-Gallego, C., Aydin, S Z., Emery, P., McGonagle, D. G.,&Marzo-Ortega, H. Magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA B27. Arthritis Rheum. 65, 2274-2278 (2013
75. Brewerton, D. A., Caffrey, M., Nicholls, A., Walters, D.,&James, D. C. Acute anterior uveitis and HL-A 27. Lancet 302, 994-996 (1973
76. Wolf, S. E., Meenken, C., Moll, A. C., Haanen, J. B.,&van der Heijden, M. S. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma. BMC Cancer 13, 561 (2013
77. Yasuoka, H., et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçets disease. Arthritis Rheum. 50, 3658-3662 (2004
78. Sugita, S., Sagawa, K., Mochizuki, M., Shichijo, S.,&Itoh, K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART 1 melanoma antigen in HLA A2 patients with Vogt-Koyanagi-Harada disease. Int. Immunol. 8, 799-803 (1996
79. Shao, E. H., Menezo, V.,&Taylor, S. R. Birdshot chorioretinopathy. Curr. Opin. Ophthalmol. 25, 488-494 (2014
80. Kuiper, J. J., et al A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy. Hum. Mol. Genet. 23, 6081-6087 (2014
81. Alvarez-Navarro, C., Martin-Esteban, A., Barnea, E., Admon, A.,&Lopez de Castro, J. A. Endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphism relevant to inflammatory disease shapes the peptidome of the birdshot chorioretinopathy-Associated HLA A29:02 antigen. Mol. Cell Proteomics 14, 1770-1780 (2015
82. Sahin, Z., et al. Takayasus arteritis is associated with HLA B52, but not with HLA B 51, in Turkey. Arthritis Res. Ther. 14, R27 (2012
83. Kasuya, K., Hashimoto, Y.,&Numano, F. Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis. Heart Vessels Suppl. 7, 116-119 (1992
84. Meguro, A., et al. Genetics of Behçet disease inside and outside the MHC. Ann. Rheum. Dis. 69, 747-754 (2010
85. Remmers, E. F., et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçets disease. Nat. Genet. 42, 698-702 (2010
86. Mizuki, N., et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçets disease susceptibility loci. Nat. Genet. 42, 703-706 (2010
87. Radouane, A., et al. HLA B27 allele associated to Behçets disease and to anterior uveitis in Moroccan patients. Ann. Biol. Clin. (Paris) 69, 419-424 (2011
88. Hughes, T., et al. Identification of multiple independent susceptibility loci in the HLA region in Behçets disease. Nat. Genet. 45, 319-324 (2013
89. Chi, W., et al. Upregulated IL 23 and IL 17 in Behçet patients with active uveitis. Invest. Ophthalmol. Vis. Sci. 49, 3058-3064 (2008
90. Menon, B., et al. Interleukin 17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol. 66, 1272-1281 (2014
91. Talamonti, M., et al. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br. J. Dermatol. 169, 458-463 (2013
92. Mantas, C., Direskeneli, H., Oz, D., Yavuz, S.,&Akoglu, T. IL 8 producing cells in patients with Behçets disease. Clin. Exp. Rheumatol. 18, 249-251 (2000
93. Keller, M., et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J. Immunol. 175, 7678-7686 (2005
94. Sherlock, J. P., et al. IL 23 induces spondyloarthropathy by acting on ROR-?t+ CD3+CD4-CD8- entheseal resident T cells. Nat. Med. 18, 1069-1076 (2012
95. Yen, D., et al. IL 23 is essential for T cell-mediated colitis and promotes inflammation via IL 17 and IL 6. J. Clin. Invest. 116, 1310-1316 (2006
96. Spits, H., et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013
97. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H.,&Lanier, L. L. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA B molecules. J. Exp. Med. 180, 537-543 (1994
98. Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L.,&Colonna, M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235-1242 (1994
99. Lanier, L. L. NK cell receptors. Annu. Rev. Immunol. 16, 359-393 (1998
100. Mingari, M. C., Moretta, A.,&Moretta, L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T cell responses. Immunol. Today 19, 153-157 (1998
101. Abdullah, H., Zhang, Z., Yee, K.,&Haroon, N. KIR3DL1 interaction with HLA B27 is altered by ankylosing spondylitis associated ERAP1 and enhanced by MHC class I cross-linking. Discov. Med. 20, 79-89 (2015
102. Shafi, S. A., Stanford, M. R., Wallace, G. R.,&Hayday, A. C. The functional analysis of MICA polymorphism with an emphasis on Behçets disease. Presented at the 14th International Conference on Behçets disease [Abstract #314]. Clin. Exp. Rheumatol. 28, 109 (2010
103. Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N.,&Ahmed, R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl Acad. Sci. USA 101, 16004-16009 (2004
104. Evans, D. M., et al. Interaction between ERAP1 and HLA B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA B27 in disease susceptibility. Nat. Genet. 43, 761-767 (2011
105. Carter, J. D., et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 62, 1298-1307 (2010
106. Direskeneli, H. Autoimmunity vs autoinflammation in Behçets disease: do we oversimplify a complex disorder?. Rheumatology (Oxford) 45, 1461-1465 (2006
107. Zhao, C., et al. Retinal S antigen TH1 cell epitope mapping in patients with Behçets disease. Graefes Arch. Clin. Exp. Ophthalmol. 247, 555-560 (2009
108. Zhao, C., et al. S antigen specific T helper type 1 response is present in Behçets disease. Mol. Vis. 14, 1456-1464 (2008
109. Franke, A., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40, 1319-1323 (2008
110. ONeill, T. P. HLA B27 transgenic rats: animal model of human HLA B27 associated disorders. Toxicol. Pathol. 25, 407-408 (1997